This episode features Dr. Gurmeet Sran, Chief Clinical Data Science Officer at Dignity Health. Here, he discusses his path to Dignity Health, what the newer role of Chief Clinical Data Science Officer ...

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

The clinical research landscape is rapidly transforming. Instead of viewing patients as subjects, sponsors now use the patients’ input to help reduce the burden they face during trials. This ...

Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical TM solution, a software-as-a-service (SaaS), end-to-end clinical data ...

The field of clinical sciences encompasses every facet of patient‐centred medicine, from bedside diagnosis and therapeutic decision‐making to the integration of cutting‐edge technology in routine ...

For the last three years, the world has obsessed over generative AI that can write and create. By the end of 2026, we'll see ...

If you missed the May 27th Informational webinar, please watch the recording above. The Clinical and Translational Science Collaborative (CTSC) CTS Research Program seeks applications for 2–3-year ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...